CoChat

Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine

MOLLER, H · 1994 · European Neuropsychopharmacology

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

There is some empirical evidence that selective serotonin reuptake inhibitors reduce suicidal ideas faster than other antidepressants. These findings are well in line with the theory of a serotonergic hypofunction in suicidal patients. To test this hypothesis the data of a 6-week double-blind control-group study comparing paroxetine versus amitriptyline were analyzed with respect to suicidality. The global antidepressive efficacy was comparable under dosages of 30 mg paroxetine or 150 mg amitriptyline per day. A differentiated analysis failed to confirm the hypothesis of a faster reduction of suicidal cognitions by paroxetine.

Overview

Integrity signals

Registry

Crossref · 10.1016/0924-977x(94)90315-8

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

See all 16

Metadata

Authors
MOLLER, H.
Affiliations
University of Bonn (DE)
Corresponding author
MOLLER, H
Venue
European Neuropsychopharmacology
Publisher
Elsevier BV
Published
1994-03
Volume
4
Issue
1
Pages
55-59
ISSN
0924-977X (ISSN-L)
OpenAlex
W2101609405
Cited by
16
References
13
Citations by year
2024: 1 · 2019: 1 · 2016: 1 · 2014: 1
FWCI
2.55
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
paroxetine, amitriptyline, selective serotonin reuptake inhibitors, suicidal ideation, suicidality, antidepressant efficacy, tricyclic antidepressants, double-blind comparison
MeSH terms
Adult, Depressive Disorder, Double-Blind Method, Humans, Psychiatric Status Rating Scales, Suicide, Selective Serotonin Reuptake Inhibitors, Paroxetine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. https://app.cochat.ai/papers/10.1016/0924-977x(94)90315-8
The paper
MOLLER, H. (1994). Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. European Neuropsychopharmacology. https://doi.org/10.1016/0924-977x(94)90315-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.